Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2011

01-12-2011 | Breast Oncology

Further Expansion of the AJCC/UICC Breast Cancer Staging System to Encompass Unique Problems in the Developing World

Authors: Vijayashree Murthy, MD, Ronald S. Chamberlain, MD, MPA, FACS

Published in: Annals of Surgical Oncology | Special Issue 3/2011

Login to get access

Excerpt

Breast cancer is the most common cause of cancer death among women in both developed and developing countries. A strong relationship between cancer stage and 10-year relative survival has been reported by Bland and colleagues using data from the 1.3 million cases in the National Cancer Data Base (NCDB).1 The last three decades have witnessed significant progress in our ability to diagnose and treat breast cancer, concurrent with an increasingly complex staging system that provides and permits more precise treatment and prognostic information. Since publication in 2002, there have been numerous changes to all three components (T, N, and M) of the American Joint Committee on Cancer (AJCC)/International Union against Cancer (UICC) staging system, used both to select and report on patients in clinical trials and to aid clinicians in making reasoned judgment about appropriate treatment strategies. The 7th edition of the AJCC staging manual has incorporated important changes into the staging of breast carcinoma, which include the use of specific imaging modalities to estimate clinical tumor size, recommendations that microscopic measurement is the most accurate and preferred method to determine pT, the use of a modifier (sn) for sentinel lymph nodes, and a new M0(i+) category for the presence of circulating tumor cells detectable in blood or bone marrow. Although the 7th edition of the AJCC cancer staging manual is robust and incorporates advanced technologies such as sentinel lymph node biopsy, immunohistochemical staining, and reverse-transcription polymerase chain reaction, we believe that the current system falls short of its stated goal of addressing the global cancer burden, especially in low- and middle-income countries (LMCs) (AJCC cancer staging manual, 7th edition, p. 351). Despite sufficient expansion, the current system does not fully deal with common tumor patterns encountered in LMCs such as:
1.
Pectoral muscle fixation of the tumor without direct chest wall invasion
 
2.
Ipsilateral metastatic neck nodes above the supraclavicular level as well as contralateral axillary and supraclavicular metastatic lymph nodes
 
3.
Variable patterns of metastatic organ involvement (osseous versus lung, liver or brain metastases)
 
Literature
1.
go back to reference Bland KI, Menck HR, Scott-Conner CEH, Morrow M, Winchester DJ, Winchester DP. The National Cancer Data Base 10-year survey of breast cancer treatment at hospitals in the United States. Cancer. 1998; 83: 1262–73.PubMedCrossRef Bland KI, Menck HR, Scott-Conner CEH, Morrow M, Winchester DJ, Winchester DP. The National Cancer Data Base 10-year survey of breast cancer treatment at hospitals in the United States. Cancer. 1998; 83: 1262–73.PubMedCrossRef
2.
go back to reference Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg. 1996; 131:301–8.PubMedCrossRef Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg. 1996; 131:301–8.PubMedCrossRef
3.
go back to reference Hirose M, Suzuki H, Doi O, Nakamura S, Saiki S, Yoshitome E. Utility of 3D MR mammography in determining the choice for conservation surgery of breast cancer (abstr). Radiology. 1995; 196:115–22. Hirose M, Suzuki H, Doi O, Nakamura S, Saiki S, Yoshitome E. Utility of 3D MR mammography in determining the choice for conservation surgery of breast cancer (abstr). Radiology. 1995; 196:115–22.
4.
go back to reference Devitt JE, Michalchuk AW. Significance of contralateral axillary metastases in carcinoma of the breast. Can J Surg. 1969; 12:178–80.PubMed Devitt JE, Michalchuk AW. Significance of contralateral axillary metastases in carcinoma of the breast. Can J Surg. 1969; 12:178–80.PubMed
5.
go back to reference Daoud J, Meziou M, Kharrat M, et al. Contralateral axillary lymph node metastasis of cancer of the breast. Bull Cancer. 1998; 85: 713–5.PubMed Daoud J, Meziou M, Kharrat M, et al. Contralateral axillary lymph node metastasis of cancer of the breast. Bull Cancer. 1998; 85: 713–5.PubMed
6.
go back to reference Chen SC, Chen MF, Hwang TL, Chao TC, Lo YF, Hsueh S, et al. Prediction of supraclavicular lymph node metastasis in breast carcinoma. Int J Rad Oncol Biol Phys. 2002; 52(3): 614–9.CrossRef Chen SC, Chen MF, Hwang TL, Chao TC, Lo YF, Hsueh S, et al. Prediction of supraclavicular lymph node metastasis in breast carcinoma. Int J Rad Oncol Biol Phys. 2002; 52(3): 614–9.CrossRef
7.
go back to reference Sesterhenn AM, Albert US, Barth PJ, Wagner U, Werner JA. The status of neck node metastases in breast cancer- loco-regional or distant? Breast. 2006; 15(2): 181–6.PubMedCrossRef Sesterhenn AM, Albert US, Barth PJ, Wagner U, Werner JA. The status of neck node metastases in breast cancer- loco-regional or distant? Breast. 2006; 15(2): 181–6.PubMedCrossRef
8.
go back to reference Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat. 2000; 59: 271–8.PubMedCrossRef Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat. 2000; 59: 271–8.PubMedCrossRef
9.
go back to reference Coleman RE, Smith P, Rubens RD. Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer. 1998; 77(2):336–40.PubMedCrossRef Coleman RE, Smith P, Rubens RD. Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer. 1998; 77(2):336–40.PubMedCrossRef
Metadata
Title
Further Expansion of the AJCC/UICC Breast Cancer Staging System to Encompass Unique Problems in the Developing World
Authors
Vijayashree Murthy, MD
Ronald S. Chamberlain, MD, MPA, FACS
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1649-8

Other articles of this Special Issue 3/2011

Annals of Surgical Oncology 3/2011 Go to the issue